| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.054 | 0.4 |